AC IMMUNE SA |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.375 USD | +1.06% |
|
-3.69% | -53.00% |
| Mar. 15 | AC Immune Files $350 Million Mixed Shelf | MT |
| Mar. 14 | AC Immune SA Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Biotechnology & Medical Research
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 221M | - | - | - | |||
| 46.71B | - | |||||
| 41.8B | ||||||
| 41.52B | ||||||
| 29.55B | ||||||
| 25.78B |
- Stock Market
- Equities
- ACIU Stock
- Charts AC Immune SA
- Sector Chart